Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Meta-analyses of type-specific HPV DNA prevalence in invasive cervical cancer [15] and women with normal cytology [14, 17]

From: Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

  Invasive cervical cancer Normal
  N tested % pos 95% CI N tested % pos 95% CI
HPV16 14595 54.4 53.6–55.2 76385 2.6 2.5–2.8
HPV18 14387 15.9 15.3–16.5 76385 0.9 0.8–1.0
HPV33 13827 4.3 4.0–4.6 74141 0.5 0.4–0.5
HPV45 9843 3.7 3.3–4.1 65806 0.4 0.4–0.4
HPV31 11960 3.5 3.2–3.9 74076 0.6 0.6–0.7
HPV58 10157 3.3 2.9–3.6 72877 0.9 0.8–1.0
HPV52 9509 2.5 2.2–2.8 69030 0.9 0.8–1.0
HPV35 9507 1.7 1.5–2.0 74084 0.4 0.3–0.4
HPV59 6972 1.0 0.8–1.3 64901 0.3 0.2–0.3
HPV51 7339 0.7 0.5–0.9 67139 0.6 0.6–0.7
HPV56 7427 0.7 0.5–0.9 68121 0.5 0.5–0.6
HPV39 7078 0.6 0.5–0.9 64521 0.4 0.3–0.4
HPV68 6723 0.5 0.3–0.7 63210 0.3 0.2–0.3
HPV73 5837 0.5 0.3–0.7 44063 0.1 0.1–0.1
HPV66 6664 0.3 0.2–0.5 59774 0.4 0.3–0.4
HPV70 5159 0.2 0.1–0.4 35014 0.3 0.3–0.3
HPV82 5352 0.1 0.1–0.3 42536 0.1 0.0–0.1
HPV6 9911 0.5 0.4–0.7 58370 0.3 0.2–0.3
HPV53 not reported 44,058 0.4 0.4–0.4
HPV26 not reported 44,098 0.0 0.0–0.1
HPV85 not studied in ICC meta-analysis 9,622 0.1 0.1 – 0.1
HPV67 not studied in ICC meta-analysis 18,041 0.0 0.0 – 0.0
HPV34 not studied in ICC meta-analysis 42,588 0.0 0.0 – 0.1
HPV30 not studied in ICC meta-analysis 8,773 0.0 0.0 – 0.1
HPV97 not studied in ICC meta-analysis not studied in normal cytology meta-analysis